Putting Patients First – to screen or not to screen?
Despite evident benefits in population screening, such programmes are slow to develop.

On the role of the Pharmacist in Near Patient Testing with In Vitro Diagnostics
Practical issues surrounding the tests available for Near Patient Testing

Pharmacogenomics - 21st Century IVDs.
In the USA alone, one hundred billion dollars, or around ten percent of the health care budget, is spent on drugs.